BioPharmSignal logoBioPharmSignal

Biotech News

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress

Rigel Pharmaceuticals (RIGL)Rigel PharmaceuticalsConference / presentation

RIGL (RIGL) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is rigl.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

RIGLRigel Pharmaceuticals2026-10-19 12:05 EST

Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026

RIGLRigel Pharmaceuticals2026-11-04 14:15 EST

Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition

ZNTLZentalis2026-07-17 20:15 EST

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

ZNTLZentalis2026-10-18 22:05 EST

Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract

SNDXSyndax Pharmaceuticals2026-05-21 21:01 EST

Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data

SNDXSyndax Pharmaceuticals2026-06-02 20:01 EST

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

GERNGeron2026-11-03 13:00 EST

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

RCKTRocket Pharmaceuticals2026-10-15 11:00 EST

Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference

GERNGeron2026-06-01 12:00 EST

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

KPTIKaryopharm Therapeutics2026-05-28 11:30 EST

Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference

View all latest news

Rigel Pharmaceuticals

Hematology and Oncology Rigel Pharmaceuticals is a commercial-stage biotechnology company focused on hematologic disorders and cancer. It combines a growing portfolio of marketed medicines with internally developed and licensed clinical programs. TAVALISSE TAVALISSE, or fostamatinib, is Rigel's therapy for chronic immune...

Recent company news

RIGLRigel Pharmaceuticals2026-11-05 21:01 EST

Rigel Reports Third Quarter 2026 Financial Results

RIGLRigel Pharmaceuticals2026-11-04 14:15 EST

Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition

RIGLRigel Pharmaceuticals2026-10-29 12:05 EST

Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results

RIGLRigel Pharmaceuticals2026-10-19 12:05 EST

Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026

RIGLRigel Pharmaceuticals2026-10-02 12:05 EST

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Stock data

Close
45.71 USD
Market cap
555.43M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States